Make Better Decisions

  • Identify first generic entrants
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Covington
Moodys
Deloitte
Medtronic
Daiichi Sankyo
Citi
Fish and Richardson
Teva
Federal Trade Commission
McKesson

Generated: January 19, 2018

DrugPatentWatch Database Preview

Details for Patent: 5,760,090

« Back to Dashboard

Summary for Patent: 5,760,090
Title: Method for treating asthma using optically pure R(-) albuterol
Abstract:The optically pure R(-) isomer of albuterol, which is substantially free of the S(+) isomer, is a potent bronchodilator for relieving the symptoms associated with asthma in individuals. A method is disclosed utilizing the optically pure R(-) isomer of albuterol for treating asthma while minimizing the side effects associated with albuterol.
Inventor(s): Barberich; Timothy J. (Concord, MA), Young; James W. (Still River, MA)
Assignee: Sepracor, Inc. (Marlborough, MA)
Application Number:08/691,604
Patent Claim Types:
see list of patent claims
Use; Delivery;

Drugs Protected by US Patent 5,760,090

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

International Patents Family Members for US Patent 5,760,090

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Austria 135908 ➤ Subscribe
Australia 7174191 ➤ Subscribe
Canada 2073181 ➤ Subscribe
Germany 69118359 ➤ Subscribe
Denmark 0509036 ➤ Subscribe
European Patent Office 0509036 ➤ Subscribe
Spain 2085468 ➤ Subscribe
Greece 3020133 ➤ Subscribe
Japan 3085705 ➤ Subscribe
Japan H05503102 ➤ Subscribe
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Julphar
Medtronic
Cantor Fitzgerald
Argus Health
Cipla
Mallinckrodt
Deloitte
Chinese Patent Office
UBS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot